Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Barclays PLC (BCS) vs Tilray Brands Inc (TLRY) Price & Performance

Barclays PLCTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Barclays PLC vs Tilray Brands Inc — how do they compare? Barclays PLC trades at $27.87 (market cap $94.10B), while Tilray Brands Inc trades at $4.74 (market cap $601.34M). The key difference: Barclays PLC is far larger — about 156.5× Tilray Brands Inc's market cap, and Barclays PLC pays a 2.18% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

BCSTLRY
Market Cap
$94.10B$601.34M
Sector
FinancialsHealth
52-Week High
$28.56$21.00
52-Week Low
$19.36$3.88
Dividend Yield
2.18%
Enterprise Value
$768.47M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Barclays PLC

Barclays PLC (BCS) trades at $27.93, down 0.89% on the day, with a bullish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $0.90 exceeding the $0.89 estimate. Revenue grew to $29.14 billion in 2025, with a net income margin of 25.51%. Analyst consensus is 68% buy, though recent news highlights a securities class action investigation.

The outlook for BCS is positive given earnings momentum and a low P/E of 10.73, but risks include the legal investigation and rising costs noted in Q2 2026. Investment opportunity lies in valuation discount and dividend yield, while sentiment is mixed due to near-term headwinds.

Tilray Brands Inc

TLRY trades at $4.57, up 2.93% with a bullish technical signal, though recent earnings misses and negative profitability metrics highlight fundamental challenges. The company reported record fiscal 2026 revenue of $915 million but continues to post significant net losses. Analyst sentiment is mixed with 25% buy ratings, while technical indicators show RSI near overbought levels with key support at $4.

Outlook remains cautious due to persistent losses and high valuation multiples, though revenue growth and diversification into beverages offer potential upside. Key risks include execution challenges, cannabis regulatory uncertainty, and competitive pressures in the consumer goods space.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Barclays PLC

Barclays is a universal bank headquartered in the United Kingdom. It operates via two principal segments

Read more on BCS

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY